https://crstodayeurope.com/news/oyster-point-pharma-to-present-new-scientific-analyses-at-world-cornea-congress-viii/2481117/daily0.7https://crstodayeurope.com/news/outlook-therapeutics-and-amerisourcebergen-announce-strategic-commercialization-agreement-for-ons-5010-for-the-treatment-of-wet-amd/2481116/daily0.7https://crstodayeurope.com/news/santen-and-ube-receive-fda-approval-for-omlonti-for-the-reduction-of-elevated-iop-in-patients-with-primary-open-angle-glaucoma-or-ocular-hypertension/2481115/daily0.7https://crstodayeurope.com/news/coopervision-appoints-weiwen-chen-to-lead-asia-pacific-region-expansion/2481114/daily0.7https://crstodayeurope.com/news/bausch-lomb-to-present-new-scientific-data-and-analyses-during-the-american-academy-of-ophthalmology-annual-meeting/2481113/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-webinar-for-eye-care-professionals-on-new-areds2-study-findings/2481111/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-to-present-data-at-the-american-academy-of-ophthalmology-aao-2022-annual-meeting/2481110/daily0.7https://crstodayeurope.com/news/amydis-announces-enrollment-of-first-participants-in-probe-a-phase-12a-trial-evaluating-a-novel-retinal-tracer-in-people-with-amyotrophic-lateral-sclerosis-or-parkinsons-disease/2481109/daily0.7https://crstodayeurope.com/news/thea-pharma-announces-activities-and-events-at-the-upcoming-american-academy-of-ophthalmology-aao-annual-meeting/2481108/daily0.7https://crstodayeurope.com/news/esight-assistive-device-for-visually-impaired-available-for-demonstrations-at-aao/2481104/daily0.7https://crstodayeurope.com/news/nicox-announces-last-patients-complete-final-visit-in-ncx-470-phase-3-mont-blanc-glaucoma-trial/2481100/daily0.7https://crstodayeurope.com/news/sight-sciences-omni-surgical-system-to-be-featured-in-multiple-presentations-at-the-2022-escrs/2481099/daily0.7https://crstodayeurope.com/news/meiragtxs-unveils-gene-therapy-manufacturing-facility-in-shannon-ireland/2481098/daily0.7https://crstodayeurope.com/news/alcon-presents-comprehensive-scientific-program-with-59-abstracts-at-escrs-2022/2481096/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announces-new-data-and-sustainability-activities-at-escrs/2481095/daily0.7https://crstodayeurope.com/news/bvi-announces-certification-for-its-iol-portfolio-under-the-european-medical-device-regulation/2481094/daily0.7https://crstodayeurope.com/news/glaukos-announces-positive-topline-outcomes-for-both-phase-3-pivotal-trials-of-idose-tr/2481092/daily0.7https://crstodayeurope.com/news/bausch-lomb-sponsored-visionary-report-spotlights-nations-blind-spots-on-amd/2481091/daily0.7https://crstodayeurope.com/news/world-council-of-optometry-and-alcon-to-host-dry-eye-disease-education-initiative/2481088/daily0.7https://crstodayeurope.com/news/eye-pcr-to-present-poster-presentations-on-fixoflex-a-new-intraocular-ophthalmic-implant-designed-to-hold-an-iol-inside-capsular-bag/2481087/daily0.7https://crstodayeurope.com/news/sight-sciences-announces-completion-of-enrollment-in-sahara-a-randomized-clinical-trial-of-the-tearcare-system-vs-restasis/2481086/daily0.7https://crstodayeurope.com/news/ciliatech-presents-new-concept-in-glaucoma-implants-first-to-bypass-opening-anterior-eye-chamber/2481085/daily0.7https://crstodayeurope.com/news/rayner-to-announce-launch-of-raypro-digital-health-platform-at-the-escrs/2481082/daily0.7https://crstodayeurope.com/news/trukera-medical-launches-new-scoutpro-osmolarity-system/2481081/daily0.7https://crstodayeurope.com/news/neurolens-raises-67-million-investment-to-develop-new-products-and-accelerate-adoption/2481080/daily0.7https://crstodayeurope.com/news/cellusion-and-celregen-enter-into-license-agreement-of-cls001-for-a-corneal-endothelial-cell-regenerative-therapy-in-the-greater-china/2481079/daily0.7https://crstodayeurope.com/news/escrs-launches-new-awards-program-to-foster-digital-transformation/2481078/daily0.7https://crstodayeurope.com/news/california-legislature-passes-optometric-surgery-bill/2481077/daily0.7https://crstodayeurope.com/news/tarsus-submits-new-drug-application-to-the-fda-for-tp-03-for-the-treatment-of-demodex-blepharitis/2481073/daily0.7https://crstodayeurope.com/news/american-academy-of-ophthalmology-urges-cms-to-address-prior-authorization-other-burdens-in-medicare-advantage/2481072/daily0.7https://crstodayeurope.com/news/himalayan-cataract-project-appoints-katherine-g-overbey-as-ceo/2481070/daily0.7https://crstodayeurope.com/news/lensar-announces-application-for-certification-of-the-ally-adaptive-cataract-treatment-system-in-the-eu/2481069/daily0.7https://crstodayeurope.com/news/ior-partners-welcomes-health-care-industry-veteran-as-new-president-and-ceo/2481068/daily0.7https://crstodayeurope.com/news/tearlab-announces-corporate-name-change-to-trukera-medical-targets-corneal-health/2481067/daily0.7https://crstodayeurope.com/news/samacares-prior-authorization-management-platform-available-on-the-modmed-emr/2481065/daily0.7https://crstodayeurope.com/news/glaukos-announces-more-than-1-million-istent-devices-implanted-worldwide/2481064/daily0.7https://crstodayeurope.com/news/bausch-lomb-and-novaliq-announce-fda-filing-acceptance-for-investigational-treatment-nov03-perfluorohexyloctane/2481063/daily0.7https://crstodayeurope.com/news/first-us-patient-receives-autologous-stem-cell-therapy-to-treat-dry-amd/2481061/daily0.7https://crstodayeurope.com/news/vyluma-completes-last-patient-visit-for-primary-analysis-of-pivotol-phase-iii-champ-study-evaluating-nvk002-for-the-treatment-of-myopia-progression-in-children/2481059/daily0.7https://crstodayeurope.com/news/zeiss-integrated-workflow-solutions-are-creating-the-digital-transformation-in-health-care/2481054/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-strategic-partnership-with-munich-surgical-imaging-gmbh-1/2481053/daily0.7https://crstodayeurope.com/news/itrack-canaloplasty-to-be-featured-at-the-2022-escrs-annual-meeting/2481051/daily0.7https://crstodayeurope.com/news/new-method-enables-long-lasting-imaging-of-rapid-brain-activity-in-individual-cells-deep-in-the-cortex/2483682/daily0.7https://crstodayeurope.com/news/bausch-health-continuing-process-toward-separating-bausch-lomb/2481048/daily0.7https://crstodayeurope.com/news/haag-streit-opens-new-surgical-microscope-production-site-in-aesch-switzerland/2481047/daily0.7https://crstodayeurope.com/news/essilor-agrees-to-pay-164-million-to-resolve-alleged-false-claims-act-liability-for-paying-kickbacks/2481046/daily0.7https://crstodayeurope.com/news/glaukos-licenses-iveenas-investigational-keratoconus-therapy/2481044/daily0.7https://crstodayeurope.com/news/esight-and-marathon-medical-partner-to-provide-sight-medical-devices-to-the-us-department-of-veterans-affairs/2481043/daily0.7https://crstodayeurope.com/news/oculis-announces-publication-of-phase-2-data-showing-topical-eye-drop-drug-candidate-ocs-02-relieves-persistent-ocular-discomfort-in-severe-dry-eye-disease/2481042/daily0.7https://crstodayeurope.com/news/alcon-to-acquire-aerie-pharmaceuticals/2481041/daily0.7https://crstodayeurope.com/news/sight-sciences-introduces-the-sion-the-first-bladeless-device-used-in-goniotomy/2481040/daily0.7https://crstodayeurope.com/news/study-bioengineered-cornea-can-restore-sight-to-the-blind-and-visually-impaired/2481039/daily0.7https://crstodayeurope.com/news/sav-iol-to-showcase-new-iol-technology-at-escrs-2022/2481038/daily0.7https://crstodayeurope.com/news/bvi-installs-first-beyeonics-one-system/2481035/daily0.7https://crstodayeurope.com/news/escrs-delegates-invited-to-attend-a-cataract-surgery-virtual-reality-vr-training-experience/2481034/daily0.7https://crstodayeurope.com/news/visibly-becomes-first-fda-cleared-online-vision-test-in-the-united-states/2481033/daily0.7https://crstodayeurope.com/news/oyster-point-pharma-announces-tyrvana-to-be-covered-by-the-largest-medicare-pharmacy-benefit-manager/2481032/daily0.7https://crstodayeurope.com/news/versea-holdings-names-rob-sambursky-md-as-president-to-lead-the-companys-expansion-into-the-ophthalmic-market/2483681/daily0.7https://crstodayeurope.com/news/first-sbl-3-clearview-multifocal-intraocular-lens-implanted-in-us/2481031/daily0.7https://crstodayeurope.com/news/sight-sciences-announces-long-term-safety-and-effectiveness-data-of-standalone-use-of-the-omni-surgical-system-in-patients-with-open-angle-glaucoma/2481030/daily0.7https://crstodayeurope.com/news/first-patients-treated-with-lensars-ally-adaptive-cataract-treatment-system/2481029/daily0.7https://crstodayeurope.com/news/viridian-announces-positive-initial-clinical-data-from-ongoing-phase-12-trial-evaluating-vrdn-001-in-patients-with-thyroid-eye-disease-ted/2481028/daily0.7https://crstodayeurope.com/news/opthea-announces-financing-deals-for-opt-302-in-wet-amd/2481027/daily0.7https://crstodayeurope.com/news/coopervision-misight-1-day-officially-launches-in-china/2481026/daily0.7https://crstodayeurope.com/news/research-to-prevent-blindness-and-the-american-academy-of-ophthalmology-award-new-research-grants-to-improve-eye-care/2481025/daily0.7https://crstodayeurope.com/news/staar-surgical-partners-with-joe-jonas-to-introduce-new-evo-icl/2481024/daily0.7https://crstodayeurope.com/news/proqr-to-focus-exclusively-on-axiomer-rna-editing-technology-and-partner-ophthalmology-programs/2481023/daily0.7https://crstodayeurope.com/news/high-tech-imaging-reveals-details-about-rare-eye-disorder/2481022/daily0.7https://crstodayeurope.com/news/alimera-announces-reimbursement-of-uveitis-indication-granted-for-iluvien-in-portugal/2481021/daily0.7https://crstodayeurope.com/news/clearside-biomedical-enters-into-non-dilutive-financing-agreement-with-healthcare-royalty-partners-for-up-to-65-million/2481020/daily0.7https://crstodayeurope.com/news/alcons-sue-jean-lin-named-2022-us-national-cio-of-the-year/2481019/daily0.7https://crstodayeurope.com/news/new-book-now-available-cataract-surgery-advanced-techniques-for-complex-and-complicated-cases/2481018/daily0.7https://crstodayeurope.com/news/neurolenses-have-significant-impact-on-reading-speed/2481017/daily0.7https://crstodayeurope.com/news/orbis-and-alcon-to-kick-off-two-week-training-for-caribbean-eye-care-teams-to-help-fight-avoidable-blindness-in-local-communities/2481016/daily0.7https://crstodayeurope.com/news/tarsus-initiates-phase-2a-ersa-trial-evaluating-tp-03-for-the-treatment-of-meibomian-gland-disease/2481015/daily0.7https://crstodayeurope.com/news/nova-eye-medical-announces-global-data-registry-to-support-role-of-canaloplasty-for-glaucoma/2481014/daily0.7https://crstodayeurope.com/news/glaukos-receives-fda-510k-clearance-for-the-istent-infinite/2481013/daily0.7https://crstodayeurope.com/news/ocuphire-extends-us-patent-protection-for-drug-candidate-nyxol-for-reversal-of-mydriasis-by-5-more-years-into-2039/2481011/daily0.7https://crstodayeurope.com/news/nei-mourns-the-loss-of-dr-michael-steinmetz/2483680/daily0.7https://crstodayeurope.com/news/high-tech-imaging-offers-new-way-to-detect-signs-of-early-glaucoma/2481008/daily0.7https://crstodayeurope.com/news/lumithera-purchases-maculogix-assets/2481007/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-first-participant-dosed-in-the-comet-3-study-of-ar-15512-for-the-treatment-of-dry-eye-disease/2481006/daily0.7https://crstodayeurope.com/news/new-app-designed-to-use-artificial-intelligence-to-reduce-digital-eye-strain/2481004/daily0.7https://crstodayeurope.com/news/dr-reddys-laboratories-enters-into-a-licensing-agreement-to-obtain-rights-for-the-private-label-version-of-lumify-in-the-us/2481003/daily0.7https://crstodayeurope.com/news/lenstec-receives-fda-approval-for-sbl-3-multifocal-iol/2481002/daily0.7https://crstodayeurope.com/news/nicox-appoints-jean-francois-labbe-as-chairman-of-the-board-of-directors/2481001/daily0.7https://crstodayeurope.com/news/edward-j-holland-md-to-join-alcon-as-member-of-the-research-and-development-team/2481000/daily0.7https://crstodayeurope.com/news/eyecare-partners-expands-presence-in-virginia-with-two-acquisitions/2480998/daily0.7https://crstodayeurope.com/news/health-initiative-tackles-burden-of-vision-impairment-for-marginalized-communities/2483679/daily0.7https://crstodayeurope.com/news/yuyu-pharma-announces-first-patient-enrolled-in-phase-2-clinical-study-evaluating-yp-p10-ophthalmic-solution-for-the-treatment-of-dry-eye-disease/2480996/daily0.7https://crstodayeurope.com/news/haag-streit-to-host-eyestar-swept-source-oct-cutting-edge-diagnostics-for-cataract-refractive-surgery-satellite-symposium/2480995/daily0.7https://crstodayeurope.com/news/atsena-therapeutics-announces-opening-of-new-office-and-laboratory-space-in-north-carolinas-research-triangle/2480994/daily0.7https://crstodayeurope.com/news/mobile-optix-promotes-lorena-brownell-to-president/2480991/daily0.7https://crstodayeurope.com/news/rd-fund-announces-new-chair-and-expansion-of-board-of-directors/2480990/daily0.7https://crstodayeurope.com/news/bausch-lomb-enrolls-first-patient-in-lasik-clinical-trial-evaluating-use-of-technolas-teneo-excimer-laser-for-vision-correction-surgery-for-hyperopia-with-astigmatism/2480988/daily0.7https://crstodayeurope.com/news/schwind-eye-tech-solutions-receives-funding-for-laser-surgery-project/2480987/daily0.7https://crstodayeurope.com/news/acufocus-announces-fda-approval-for-the-ic-8-apthera-iol-the-first-and-only-small-aperture-lens-for-cataract-surgery/2480986/daily0.7https://crstodayeurope.com/news/carl-zeiss-meditec-and-precise-bio-announce-partnership-in-the-development-and-commercialization-of-tissue-based-implants-for-ophthalmology/2480984/daily0.7https://crstodayeurope.com/news/joseph-c-papa-to-step-down-from-ceo-role-at-bausch-lomb/2480983/daily0.7https://crstodayeurope.com/news/abbvie-and-istar-medical-announce-strategic-alliance/2480980/daily0.7https://crstodayeurope.com/news/nora-response-to-medical-groups-joint-guidance-of-vision-disorders-following-a-concussion/2480978/daily0.7https://crstodayeurope.com/news/aao-what-ophthalmologists-want-you-to-know-about-kids-and-concussion/2483678/daily0.7https://crstodayeurope.com/news/bausch-lomb-and-novaliq-submission-new-drug-application-for-investigational-nov03-for-dry-eye-disease-associated-with-mgd/2480972/daily0.7https://crstodayeurope.com/news/eyenovia-provides-manufacturing-update-and-announces-appointment-of-bren-kern-as-svp-of-manufacturing-and-operations/2480971/daily0.7https://crstodayeurope.com/news/new-app-allows-surgeons-to-search-for-fda-approved-iols/2480969/daily0.7https://crstodayeurope.com/news/after-building-new-plant-and-signing-on-with-abbvie-regenxbio-enters-commercial-phase/2480967/daily0.7https://crstodayeurope.com/news/prevent-blindness-holds-11th-annual-focus-on-eye-health-national-summit-as-two-day-virtual-event/2480966/daily0.7https://crstodayeurope.com/news/euclid-vision-announces-official-launch-of-cloud-based-portal/2480964/daily0.7https://crstodayeurope.com/news/xequel-bio-announces-positive-results-from-phase-1b-study-of-inexin-a-novel-act1-ophthalmic-solution/2480963/daily0.7https://crstodayeurope.com/news/zeiss-ventures-invests-in-morrow-eyewear/2480961/daily0.7https://crstodayeurope.com/news/study-blinding-eye-disease-is-strongly-associated-with-heart-disease-and-stroke/2480958/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-achieves-primary-endpoints-in-dry-eye-disease-chamber-crossover-clinical-trial/2480957/daily0.7https://crstodayeurope.com/news/rayner-establishes-direct-presence-in-france/2480956/daily0.7https://crstodayeurope.com/news/glasgow-eye-department-now-using-ocular-simulation-training-through-drv-system/2480954/daily0.7https://crstodayeurope.com/news/global-data-increasing-cataract-surgical-rates-will-drive-artificial-lenses-market-to-reach-47-billion-by-2030/2480953/daily0.7https://crstodayeurope.com/news/novartis-acquires-kedalion-therapeutics-and-its-ocular-delivery-platform/2480952/daily0.7https://crstodayeurope.com/news/nicox-announces-publication-of-ncx-470-results-demonstrating-improvements-to-ocular-hemodynamics-and-retinal-cell-physiology-1/2480951/daily0.7https://crstodayeurope.com/news/ocuphire-announces-late-breaking-paper-for-nyxol-for-reversal-of-dilation-indication-at-annual-asrs-meeting/2480950/daily0.7https://crstodayeurope.com/news/eyenovia-strategic-partner-arctic-vision-enrolls-first-patient-in-phase-iii-clinical-trial-of-arvn003-microline-for-presbyopia-in-china-1/2483677/daily0.7https://crstodayeurope.com/news/measuring-levels-of-proteins-in-eye-fluid-may-accurately-predict-need-for-lifelong-macular-degeneration-therapy/2480947/daily0.7https://crstodayeurope.com/news/sav-iol-continues-progress-on-electronic-iol-project/2480946/daily0.7https://crstodayeurope.com/news/aetna-drops-prior-authorization-requirement-for-cataract-surgery/2480944/daily0.7https://crstodayeurope.com/news/efficacy-of-notal-vision-home-oct-demonstrated-by-a-series-of-scientific-and-clinical-work/2480942/daily0.7https://crstodayeurope.com/news/oculis-announces-first-patient-enrolled-in-phase-3-optimize-trial-of-ocs-01-in-the-treatment-of-inflammation-and-pain-following-cataract-surgery/2480939/daily0.7https://crstodayeurope.com/news/oyster-point-pharma-announces-operating-expense-streamlining-plan/2480938/daily0.7https://crstodayeurope.com/news/formosa-pharmaceuticals-and-aimmax-therapeutics-announce-successful-topline-results-from-cpn-301-for-the-treatment-of-inflammation-and-pain-after-cataract-surgery/2480937/daily0.7https://crstodayeurope.com/news/graybug-announces-review-of-strategic-alternatives/2480935/daily0.7https://crstodayeurope.com/news/npr-report-he-and-his-wife-both-got-cataract-surgery-his-bill-was-20-times-higher-than-hers/2480934/daily0.7https://crstodayeurope.com/news/kuria-therapeutics-and-scohia-pharma-announce-licensing-agreement-for-ophthalmic-and-dermal-rights-to-sco-116-a-novel-nrf2-activator/2480933/daily0.7https://crstodayeurope.com/news/essilorluxottica-chairman-leonardo-del-vecchio-passes-away-at-age-87/2480931/daily0.7https://crstodayeurope.com/news/harrow-health-announces-launch-of-iopidine-1-and-maxitrol-in-the-united-states/2480929/daily0.7https://crstodayeurope.com/news/brim-biotechnology-enters-otc-trading-in-taiwan/2480926/daily0.7https://crstodayeurope.com/news/bausch-lomb-receives-permanent-j-code-for-xipere-from-cms/2483676/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-and-ocumension-therapeutics-announce-approval-of-nda-by-chinas-nmpa-for-uveitis-treatment-yutiq/2480925/daily0.7https://crstodayeurope.com/news/foundation-fighting-blindness-announces-leadership-changes/2480924/daily0.7https://crstodayeurope.com/news/opus-genetics-appoints-ben-yerxa-phd-as-permanent-chief-executive-officer/2480923/daily0.7https://crstodayeurope.com/news/ace-vision-group-appoints-elizabeth-yeu-md-as-chief-strategic-advisor/2480922/daily0.7https://crstodayeurope.com/news/nanodropper-announces-increases-in-partnerships-and-availability/2480921/daily0.7https://crstodayeurope.com/news/lighthouse-guild-awards-college-scholarships-of-10000-each-to-15-students-who-are-blind-or-visually-impaired/2480919/daily0.7https://crstodayeurope.com/news/reichert-celebrates-100-year-anniversary-of-the-first-phoroptor-refracting-instrument-model/2480918/daily0.7https://crstodayeurope.com/news/aao-provides-new-goniotomy-guidelines/2480916/daily0.7https://crstodayeurope.com/news/nacuity-pharmaceuticals-announces-165-million-series-b-financing-led-by-foundation-fighting-blindness-rd-fund/2480913/daily0.7https://crstodayeurope.com/news/new-study-shows-intraocular-lens-centration-and-stability-may-be-improved-when-zepto-capsulotomy-platform-is-used-with-purkinje-reflections/2480912/daily0.7https://crstodayeurope.com/news/vyluma-and-laboratoires-thea-enter-into-licensing-agreement-commercialization-of-childhood-myopia-drug/2480911/daily0.7https://crstodayeurope.com/news/lensar-receives-fda-clearance-of-the-ally-adaptive-cataract-treatment-system/2480910/daily0.7https://crstodayeurope.com/news/istar-medical-presents-positive-results-for-miniject-across-three-international-glaucoma-trials/2480908/daily0.7https://crstodayeurope.com/news/first-of-its-kind-study-finds-artificial-intelligence-screenings-improve-eye-care-access-in-sub-saharan-africa/2480906/daily0.7https://crstodayeurope.com/news/aurion-biotech-appoints-dr-michael-goldstein-as-president-and-chief-medical-officer/2480904/daily0.7https://crstodayeurope.com/news/nacuity-pharmaceuticals-strengthens-scientific-advisory-board-with-appointment-of-nancy-holekamp-md-and-richard-l-lindstrom-md/2480903/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-achieves-primary-endpoint-in-phase-3-tranquility2-trial-in-dry-eye-disease/2480902/daily0.7https://crstodayeurope.com/news/rayner-acquires-stake-in-sustainable-surgical-instrument-belgian-manufacturer-hasa-optix/2480900/daily0.7https://crstodayeurope.com/news/sifi-announces-ema-validation-of-its-marketing-authorization-application-for-akantior-for-the-treatment-of-acanthamoeba-keratitis/2480899/daily0.7https://crstodayeurope.com/news/eyenovia-announces-planned-chief-executive-officer-transition/2480898/daily0.7https://crstodayeurope.com/news/staar-surgical-celebrates-2-million-lens-milestone-for-implantable-collamer-lens-icl/2480897/daily0.7https://crstodayeurope.com/news/nicox-now-expects-topline-results-from-ncx-470-mont-blanc-phase-3-glaucoma-trial-in-november-2022/2480892/daily0.7https://crstodayeurope.com/news/oertli-expands-its-direct-distribution-network/2480889/daily0.7https://crstodayeurope.com/news/market-scope-global-pc-iol-demand-rises-modestly-soars-in-a-few-countries/2480888/daily0.7https://crstodayeurope.com/news/newly-published-12-month-clinical-data-for-sight-sciences-omni-surgical-system/2480887/daily0.7https://crstodayeurope.com/news/artificial-intelligence-in-ophthalmology-2022-conference-is-being-held-online/2480884/daily0.7https://crstodayeurope.com/news/ann-rast-joins-mobile-optix-as-director-of-clinical-operations/2483675/daily0.7https://crstodayeurope.com/news/reuters-app-to-help-blind-people-navigate-public-transit-to-debut-in-washington/2483674/daily0.7https://crstodayeurope.com/news/lumenis-optilight-wins-2022-medtech-breakthrough-award-best-new-technology-solution-for-ophthalmology/2480882/daily0.7https://crstodayeurope.com/news/dopavision-appoints-mark-s-wuttke-phd-as-chief-executive-officer/2480881/daily0.7https://crstodayeurope.com/news/ama-health-insurance-industry-continues-to-falter-on-prior-authorization-reform/2480880/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-first-participant-dosed-in-the-phase-3-comet-2-study-of-ar-15512-for-the-treatment-of-dry-eye-disease/2480879/daily0.7https://crstodayeurope.com/news/new-guide-from-who-aims-to-tackle-growing-eye-health-crisis/2483673/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-to-sell-eysuvis-and-inveltys-to-alcon/2480878/daily0.7https://crstodayeurope.com/news/the-vision-council-releases-provider-insights-q1-2022-report/2480877/daily0.7https://crstodayeurope.com/news/haag-streit-launches-4th-slit-lamp-imaging-competition/2480876/daily0.7https://crstodayeurope.com/news/holland-foundation-for-sight-restoration-appoints-kila-hanrahan-director-of-development/2480875/daily0.7https://crstodayeurope.com/news/new-study-highlights-patient-willingness-to-adhere-to-pre-op-prep/2480874/daily0.7https://crstodayeurope.com/news/alcon-volunteers-strengthen-communities-across-the-globe-with-alcon-in-action/2483672/daily0.7https://crstodayeurope.com/news/ocuphire-announces-positive-topline-results-from-lynx-1-phase-3-trial-evaluating-nyxol-eye-drops-for-night-vision-disturbances/2480873/daily0.7https://crstodayeurope.com/news/visiox-pharma-appoints-ryan-s-bleeks-as-chief-executive-officer/2480872/daily0.7https://crstodayeurope.com/news/qlaris-bio-reports-phase-2-clinical-trial-results-demonstrating-favorable-safety-and-tolerability-profile-and-positive-efficacy-signal-for-qls-101/2480871/daily0.7https://crstodayeurope.com/news/united-kingdom-first-to-grant-license-for-tevas-ophthalmology-biosimilar-ongavia-ranibizumab/2480870/daily0.7https://crstodayeurope.com/news/prevent-blindness-and-aerie-pharmaceuticals-partner-to-offer-new-glaucoma-research-grant/2480868/daily0.7https://crstodayeurope.com/news/brim-biotechnology-and-ora-inc-announce-new-partnership-to-accelerate-development-of-regenerative-peptide-therapy-brm421-for-dry-eye-syndrome/2480867/daily0.7https://crstodayeurope.com/news/euclid-vision-names-dr-zohra-fadli-as-global-head-of-rd-and-clinical-affairs/2483671/daily0.7https://crstodayeurope.com/news/2022-bressler-prize-awarded-to-dr-sheila-nirenberg-for-outstanding-accomplishments-in-vision-science/2480866/daily0.7https://crstodayeurope.com/news/allotex-announces-eye-bank-executive-joining-board-of-directors/2480864/daily0.7https://crstodayeurope.com/news/visionix-and-right-mfg-to-enter-a-long-term-strategic-partnership/2480863/daily0.7https://crstodayeurope.com/news/alcon-celebrates-75-years-of-eye-care-innovation/2480862/daily0.7https://crstodayeurope.com/news/ophthalmologist-ashley-brissette-md-launches-new-eye-area-skincare-line-daily-practice/2480861/daily0.7https://crstodayeurope.com/news/horizon-therapeutics-launches-letter-writing-campaign-to-empower-those-living-with-thyroid-eye-disease-ted-to-confront-the-condition-head-on/2480860/daily0.7https://crstodayeurope.com/news/belkin-visions-eagle-receives-ce-mark-under-mdr/2480859/daily0.7https://crstodayeurope.com/news/life-after-death-for-the-human-eye-vision-scientists-revive-light-sensing-cells-in-organ-donor-eyes/2480858/daily0.7https://crstodayeurope.com/news/the-american-academy-of-ophthalmology-commends-congress-for-reaching-significant-milestone-on-prior-authorization-reform-bill/2480857/daily0.7https://crstodayeurope.com/news/study-shows-highest-iol-prediction-accuracy-for-hill-rbf-30/2480856/daily0.7https://crstodayeurope.com/news/haag-streits-octopus-900-driving-perimetry-test-first-to-comply-with-eu-commission-directive/2483670/daily0.7https://crstodayeurope.com/news/eyevensys-recaps-highlights-from-investigator-meeting-and-presentations-at-arvo/2480854/daily0.7https://crstodayeurope.com/news/xequel-bio-appoints-veteran-pharmaceutical-executives-to-advance-next-stage-of-corporate-growth/2483669/daily0.7https://crstodayeurope.com/news/visus-therapeutics-and-zhaoke-ophthalmology-announce-exclusive-licensing-agreement-to-commercialize-brimocholtm-pf-and-carbachol-pf-in-greater-china-south-korea-and-select-southeast-asian-markets-for-the-treatment-of-presbyopia/2483668/daily0.7https://crstodayeurope.com/news/upneeq-wins-best-professional-treatment-product-by-shape-magazine/2483667/daily0.7https://crstodayeurope.com/news/istar-medical-expands-commercial-rollout-with-first-miniject-surgeries-in-switzerland/2480852/daily0.7https://crstodayeurope.com/news/bausch-lomb-corporation-launches-as-a-publicly-traded-company/2480851/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-launches-its-first-direct-to-consumer-campaign-to-increase-awareness-of-dry-eye-flares/2480850/daily0.7https://crstodayeurope.com/news/nova-eye-medical-reports-canaloplasty-data-demonstrating-sustained-reduction-in-iop-with-itrack/2480849/daily0.7https://crstodayeurope.com/news/skye-bioscience-reports-enhanced-iop-lowering-of-sbi-100-formulation/2480846/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-to-present-at-mod-live-2022-meeting/2480843/daily0.7https://crstodayeurope.com/news/zeiss-offers-new-slt-application-for-the-visulas-green-therapeutic-laser/2480842/daily0.7https://crstodayeurope.com/news/sav-iol-launches-instant-focus-edof-iol-technology/2480841/daily0.7https://crstodayeurope.com/news/jj-vision-presents-new-data-on-myopia-iols-phacoemulsification-dry-eye-drops-vision-science-and-refractive-technologies-at-arvo/2480839/daily0.7https://crstodayeurope.com/news/bausch-lomb-presents-data-from-second-pivotal-phase-3-trial-of-investigational-treatment-nov03-at-arvo/2480837/daily0.7https://crstodayeurope.com/news/dr-bettina-hohberger-receives-heidelberg-engineering-xtreme-research-award-2022/2483666/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-appoints-peter-menziuso-as-company-group-chairman/2480835/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-announces-new-commercial-and-medicare-coverage-for-eysuvis/2480834/daily0.7https://crstodayeurope.com/news/ora-unveils-ophthalmic-research-technologies-at-arvo-2022/2480833/daily0.7https://crstodayeurope.com/news/coopervision-seeks-proposals-for-2022-science-and-technology-awards/2480832/daily0.7https://crstodayeurope.com/news/funding-awarded-to-ophthalmologists-using-big-data-to-improve-patient-care/2480828/daily0.7https://crstodayeurope.com/news/tarsus-announces-positive-topline-data-from-saturn-2-phase-3-the-second-pivotal-trial-of-tp-03-for-the-treatment-of-demodex-blepharitis/2480827/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-to-present-clinical-data-for-kpi-012-its-mesenchymal-stem-cell-secretome-product-for-the-treatment-of-pced-at-arvo/2480824/daily0.7https://crstodayeurope.com/news/sightglass-vision-presents-24-month-data-demonstrating-myopia-control-efficacy-for-vision-spectacle-lenses/2480823/daily0.7https://crstodayeurope.com/news/nicox-presents-phase-2-results-on-ncx-4251-and-new-nonclinical-evidence-of-improved-hemodynamic-and-retinal-cell-physiology-on-ncx-470/2480822/daily0.7https://crstodayeurope.com/news/heidelberg-engineering-presents-various-scientific-innovations-at-arvo/2480819/daily0.7https://crstodayeurope.com/news/verana-health-unveils-annual-ophthalmic-industry-report-that-shows-a-more-than-80-glaucoma-surgery-uptake-over-8-year-period-1/2480818/daily0.7https://crstodayeurope.com/news/allergan-to-present-new-data-from-its-portfolio-of-eye-care-treatments-at-arvo/2480817/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-launch-of-ipo/2480816/daily0.7https://crstodayeurope.com/news/bausch-lomb-will-present-new-scientific-data-and-analyses-on-products-and-pipeline-programs-during-arvo/2480814/daily0.7https://crstodayeurope.com/news/ocuphire-completes-last-clinical-trial-supporting-the-planned-2022-nda-submission-of-nyxol-for-reversal-of-mydriasis/2480812/daily0.7https://crstodayeurope.com/news/american-academy-of-optometry-announces-the-2022-arvo-student-travel-fellowship-grant-recipients/2480811/daily0.7https://crstodayeurope.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-annual-conference/2480810/daily0.7https://crstodayeurope.com/news/graybug-to-present-preclinical-data-for-gb-401-in-primary-open-angle-glaucoma-at-the-2022-arvo-annual-meeting/2480808/daily0.7https://crstodayeurope.com/news/oyster-point-pharma-to-present-new-analyses-at-arvo-2022/2480807/daily0.7https://crstodayeurope.com/news/visus-therapeutics-announces-new-scientific-data-to-be-presented-during-the-2022-arvo-annual-meeting/2480805/daily0.7https://crstodayeurope.com/news/schwind-celebrates-30-years-in-refractive-corneal-surgery/2480804/daily0.7https://crstodayeurope.com/news/tarsus-presents-results-of-two-studies-highlighting-demodex-blepharitis-patient-impact-and-burden-at-the-ascrs-2022-annual-meeting/2480803/daily0.7https://crstodayeurope.com/news/bausch-lomb-presents-data-from-first-pivotal-phase-3-trial-of-investigational-nov03-at-ascrs/2480800/daily0.7https://crstodayeurope.com/news/mitochondria-double-as-tiny-lenses-in-the-eye/2480799/daily0.7https://crstodayeurope.com/news/ophthalmic-organizations-release-position-statement-on-multidose-topical-medications-for-ophthalmic-surgery/2480798/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-to-present-preclinical-and-clinical-data-at-the-2022-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting/2480797/daily0.7https://crstodayeurope.com/news/thea-introduces-ivizia-otc-eye-care-products-in-us/2480796/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-introduces-next-generation-tearscience-activator-clear-for-treatment-of-mgd/2480795/daily0.7https://crstodayeurope.com/news/haag-streit-launches-the-eyestar-900-anterior-chamber-suite/2480794/daily0.7https://crstodayeurope.com/news/verana-health-unveils-annual-ophthalmic-industry-report-that-shows-a-more-than-80-glaucoma-surgery-uptake-over-8-year-period/2480793/daily0.7https://crstodayeurope.com/news/ziemer-receives-fda-clearance-for-the-femto-z8-neo/2480792/daily0.7https://crstodayeurope.com/news/envision-invites-students-across-the-country-who-are-blind-or-visually-impaired-to-prepare-for-college-and-careers-with-annual-level-up-technology-camp/2480791/daily0.7https://crstodayeurope.com/news/corneagen-advances-next-generation-of-dsek-surgery-innovation/2480789/daily0.7https://crstodayeurope.com/news/glaukos-technologies-featured-in-numerous-scientific-abstracts-at-the-2022-ascrs/2480788/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-presents-data-validating-improved-surgical-outcomes-and-surgeon-satisfaction-across-cataract-and-refractive-portfolio-at-ascrs/2480787/daily0.7https://crstodayeurope.com/news/refractive-surgery-council-reports-more-than-200000-laser-vision-correction-procedures-performed-in-q1-2022/2480786/daily0.7https://crstodayeurope.com/news/orasis-announces-positive-phase-3-topline-results-of-novel-eye-drop-candidate-csf-1-for-the-treatment-of-presbyopia/2480784/daily0.7https://crstodayeurope.com/news/centricity-vision-announces-new-technologies-under-development-zeptolink-and-55-mm-capsulotomy-names-leonard-borrmann-to-lead-rd/2480783/daily0.7https://crstodayeurope.com/news/alcon-announces-scientific-program-at-ascrs-2022/2480782/daily0.7https://crstodayeurope.com/news/euclid-vision-announces-acquisition-of-visionary-optics/2480780/daily0.7https://crstodayeurope.com/news/zeiss-announces-fda-clearance-of-the-quatera-700-phaco-technology/2480779/daily0.7https://crstodayeurope.com/news/allergan-to-present-new-data-from-its-eye-care-portfolio-at-ascrs-2022/2480778/daily0.7https://crstodayeurope.com/news/ocuphire-appoints-jay-pepose-md-phd-as-chief-medical-advisor-and-announces-upcoming-presentations-at-ascrs-2022-and-eyecelerator/2480777/daily0.7https://crstodayeurope.com/news/eyenovia-announces-poster-presentation-at-ascrs-2022/2480776/daily0.7https://crstodayeurope.com/news/oyster-point-pharma-to-present-new-clinical-data-at-ascrs-2022/2480775/daily0.7https://crstodayeurope.com/news/nova-eye-medical-launches-next-generation-canaloplasty-device-for-glaucoma-itrack-advance/2480774/daily0.7https://crstodayeurope.com/news/shamir-announces-changes-in-executive-leadership/2480772/daily0.7https://crstodayeurope.com/news/ultrasound-gave-us-our-first-baby-pictures-can-it-also-help-the-blind-see/2480771/daily0.7https://crstodayeurope.com/news/graybug-to-present-at-the-2022-ascrs-annual-meeting/2480770/daily0.7https://crstodayeurope.com/news/bausch-lomb-will-present-new-scientific-data-during-the-ascrs-annual-meeting/2480769/daily0.7https://crstodayeurope.com/news/envision-university-sets-agenda-for-in-person-may-2022-conference/2480768/daily0.7https://crstodayeurope.com/news/lumibird-medical-launches-new-ndyag-laser-capsulo/2480767/daily0.7https://crstodayeurope.com/news/orasis-pharmaceuticals-to-present-new-data-on-novel-presbyopia-candidate-at-ascrs/2480764/daily0.7https://crstodayeurope.com/news/love-your-eyes-confirmed-as-the-theme-for-world-sight-day-2022/2480763/daily0.7https://crstodayeurope.com/news/recipients-of-the-2022-prevent-blindness-jenny-pomeroy-award-for-excellence-in-vision-and-public-health-and-rising-visionary-award-announced/2480762/daily0.7https://crstodayeurope.com/news/alcon-introduces-virtual-reality-surgical-training-technology/2480761/daily0.7https://crstodayeurope.com/news/aurion-biotech-raises-120-million-to-advance-its-cell-therapy-program/2480760/daily0.7https://crstodayeurope.com/news/bruder-introduces-in-office-package-options-for-moist-heat-eye-compress/2480759/daily0.7https://crstodayeurope.com/news/nicoxs-ncx-470-dolomites-phase-2-results-published-in-journal-of-glaucoma/2480758/daily0.7https://crstodayeurope.com/news/study-people-with-vision-impairments-up-to-four-times-more-likely-to-suffer-mental-health-problems/2480757/daily0.7https://crstodayeurope.com/news/aao-to-lobby-congress-on-key-issues/2483665/daily0.7https://crstodayeurope.com/news/upneeq-wins-best-in-innovation-award-from-new-beauty/2483664/daily0.7https://crstodayeurope.com/news/actress-kate-walsh-teams-up-with-alcon-for-dry-eye-campaign/2480754/daily0.7https://crstodayeurope.com/news/axim-biotech-develops-rapid-quantitative-tear-test-for-mmp-9-an-inflammatory-biomarker-of-dry-eye-disease/2480753/daily0.7https://crstodayeurope.com/news/zeiss-to-unveil-clinical-insights-supporting-the-value-of-new-data-driven-digital-workflow-solutions-and-software-applications/2480752/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-first-implants-of-evo-visian-icl-in-the-us/2480751/daily0.7https://crstodayeurope.com/news/allergan-announces-positive-topline-phase-3-results-evaluating-twice-daily-administration-of-vuity-in-adults-with-presbyopia/2480749/daily0.7https://crstodayeurope.com/news/alcon-launches-systane-ilux2-mgd-thermal-pulsation-system-for-dry-eye-disease/2480748/daily0.7https://crstodayeurope.com/news/genentech-launches-first-retina-study-in-underrepresented-patient-populations/2480747/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-to-present-phase-1b-clinical-data-for-kpi-012-in-patients-with-pced-at-2022-arvo-annual-meeting/2483663/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-announces-completion-of-enrollment-in-phase-3-tranquility-2-trial-in-patients-with-dry-eye-disease/2480746/daily0.7https://crstodayeurope.com/news/shamir-group-employees-around-the-world-are-mobilized-for-humanitarian-aid-for-ukrainian-refugees-in-warsaw/2480745/daily0.7https://crstodayeurope.com/news/researchers-identify-how-multiple-genes-impact-vision-development-and-result-in-rare-sight-disorder/2480744/daily0.7https://crstodayeurope.com/news/retina-consultants-of-america-partners-with-associated-vitreoretinal-and-uveitis-consultants-in-indiana/2480743/daily0.7https://crstodayeurope.com/news/researchers-generate-first-complete-gapless-sequence-of-a-human-genome/2480741/daily0.7https://crstodayeurope.com/news/heru-featured-in-scientific-program-with-hands-on-demonstrations-at-the-2022-vision-expo-east-annual-meeting/2480739/daily0.7https://crstodayeurope.com/news/olympic-ophthalmics-announces-fda-clearance-and-availability-of-its-next-generation-itear100-neurostimulation-device-expanded-patent-portfolio-and-further-clinical-studies/2480737/daily0.7https://crstodayeurope.com/news/luneau-technology-launches-as-visionix-to-manufacture-and-sell-optovue-visionix-briot-and-weco-brands/2480736/daily0.7https://crstodayeurope.com/news/nova-eye-president-appointed-to-american-glaucoma-society-ags-foundation-advisory-board/2480735/daily0.7https://crstodayeurope.com/news/study-dry-eye-disease-signs-and-symptoms-significantly-reduced-with-ciclosporin-a-01-cationic-emulsion/2480734/daily0.7https://crstodayeurope.com/news/graybug-updates-its-ophthalmic-pipeline-programs/2480733/daily0.7https://crstodayeurope.com/news/hanita-lenses-launches-joint-venture-with-ophthalmic-vision-care-in-the-iberian-peninsula/2480732/daily0.7https://crstodayeurope.com/news/icare-usa-introduces-icare-home2-self-tonometer/2480731/daily0.7https://crstodayeurope.com/news/ocuphire-announces-positive-topline-results-from-mira-3-phase-3-fda-registration-trial-for-nyxol-in-the-reversal-of-mydriasis/2480730/daily0.7https://crstodayeurope.com/news/iapb-introduces-focus-on-child-eye-health/2480729/daily0.7https://crstodayeurope.com/news/innovega-grants-commercial-license-of-its-next-generation-display-eyewear-to-global-supplier/2480728/daily0.7https://crstodayeurope.com/news/istar-medical-announces-first-miniject-surgeries-performed-in-the-uk/2480727/daily0.7https://crstodayeurope.com/news/retina-consultants-of-america-expands-washington-state-footprint-through-partnership-with-retina-center-northwest/2480726/daily0.7https://crstodayeurope.com/news/bausch-lomb-and-clearside-biomedical-announce-us-commercial-launch-of-xipere/2480725/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-fda-approval-of-evo-visian-implantable-collamer-lenses/2480724/daily0.7https://crstodayeurope.com/news/penn-researchers-develop-gene-therapy-that-restores-dim-light-vision-in-dogs/2480723/daily0.7https://crstodayeurope.com/news/sight-sciences-announces-first-patient-treated-in-trident-european-trial-to-evaluate-the-omni-surgical-system-in-pseudophakic-eyes-with-open-angle-glaucoma/2480722/daily0.7https://crstodayeurope.com/news/new-multi-language-options-now-available-on-reichertcom/2480719/daily0.7https://crstodayeurope.com/news/haag-streit-launhces-the-imaging-module-910-slit-lamp/2480718/daily0.7https://crstodayeurope.com/news/worlds-thinnest-3d-printed-cornea-implanted-in-jerusalem/2480717/daily0.7